tracking the news, one byte at a time
Freak Pulse
Category: Alzheimer’s Disease and Frontal Temporal Dementia
-
Research Reviews and Treatment Debates, 2026 Alzheimer’s disease facts figures – PMC, and more.
Research Reviews and Treatment Debates this week: The 2026 Alzheimer’s disease facts and figures report consolidates the state of early detection and treatment; and Harvard researchers Bruce Yankner, Sandeep Robert Datta, and Chenghua Gu…
-
Blood Tests and Biomarkers for Early, Alzheimer s 2026 Breakthrough, and more.
Blood Tests and Biomarkers for Early Detection this week: In 2026, Alzheimer’s disease management is being reshaped by the clinical deployment of high-precision blood; and Amsterdam UMC researchers have identified a novel cerebrospinal…
-
New Alzheimer’s Drug Trials and, Annovis Publishes Phase 2/3, and more.
New Alzheimer’s Drug Trials and Clinical Results this week: Annovis Bio has published peer-reviewed Phase 2/3 results for its oral Alzheimer’s candidate, buntanetap, in NPJ; and Annovis Bio has published peer-reviewed Phase 2/3 data for…
-
Roundup: Blood Signals, Blood test has potential detect earliest signals Alzheimer’s, and more.
Blood Signals this week: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete…
-
Roundup: Cervomed Signals, CervoMed Announces Data 2026 AAN Annual Meeting, and more.
Cervomed Signals this week: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a…
-
Roundup: New Models & AI, A human cell that tangles on its own, and more.
Research on Disease Mechanisms and New Models this week: A team at LMU Munich has engineered a human induced pluripotent stem cell (iPSC) model that endogenously expresses; and A research consortium centered at MIT has released…
-
Roundup: Dementia Research Challenges &, Blog Why Normal Cognition, and more.
Dementia Research Challenges & Community Insights this week: Preclinical Alzheimer’s trials targeting amyloid-positive but cognitively unimpaired individuals have repeatedly; and ENRICH Scotland’s Clinical Studies Officer details…
-
Roundup: Clinical Trial Results and Drug, Annovis Publishes Phase 2/3, and more.
Clinical Trial Results and Drug Development Updates this week: Annovis Bio has published Phase 2/3 results for buntanetap in mild-to-moderate Alzheimer’s disease in NPJ Dementia; and TauRx has published confirmatory study results in the…
-
Roundup: Blood Biomarkers for Dementia, p-tau217 goes commercial, and more.
Blood Tests & Biomarkers for Dementia Detection this week: A private healthcare provider, Echelon Health, is marketing a comprehensive dementia assessment that integrates the; and Rite Aid is offering p-tau217 blood testing as a…
-
Roundup: New Blood Tests and Biomarkers for, Spring 2026 Alzheimer’s Updates, and more.
New Blood Tests and Biomarkers for Early Detection this week: The Alzheimer’s disease clinical landscape is consolidating around biomarker-confirmed diagnosis and modestly; and In a 2026 update, Dr.